ResearcherTsinghua UniversityNo recent work listed

Lei Dou

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5076344295. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 2 papers

Papers 2

Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2022.07.033 ↗
Corrigendum to "Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer" [Journal of Controlled Release 349 (2022) 87… Co-author DOI 10.1016/j.jconrel.2022.08.013 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huiqin Liu · 2 shared papers, 2022 · strength 0.31
- Paper Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer. DOI 10.1016/j.jconrel.2022.07.033 ↗
- Paper Corrigendum to "Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer" [Jou… DOI 10.1016/j.jconrel.2022.08.013 ↗
Qian Feng · 1 shared paper, 2022 · strength 0.16
- Paper Corrigendum to "Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer" [Jou… DOI 10.1016/j.jconrel.2022.08.013 ↗
Feng Qian · 1 shared paper, 2022 · strength 0.16
- Paper Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer. DOI 10.1016/j.jconrel.2022.07.033 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.